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Prevalence of anticardiolipin antibodies in juvenile
chronic arthritis
R Caporali, A Ravelli, F De Gennaro, G Neirotti, C Montecucco, A Martini
Abstract
The prevalence of anticardiolipin antibodies
was evaluated in 70 children with juvenile
chronic arthritis (CA), in 25 adult patients
with rheumatoid arthritis, in 42 healthy
chiklren and in 40 adult controls. Thirty seven
(53%) patients with JCA were positive for IgG
or IgM anticardiolipin antibodies, or both,
and 30 (43%/) for IgG anticardiolipin anti-
bodies. In contrast, only seven (28%/9) adult
patients with iheumatoid arthritis presented
anticardiolipin antibodies, which were of IgG
class in four (16%) cases. IgG anticardiolipin
antibodies were negative in all control sub-
jects while IgM anticardiolipin antibodies
were detected in two (5%/6) chilren and in four
(10%) adult controls. No correlations were
found in patients with JCA between the
presence or titres of anticardiolipin antibodies
and various cfinical or laboratory variables.
No patient with anticardiolipin antibodies
showed any feature of the anticardiolipin
syndrome.
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Juvenile chronic arthritis (JCA) is an hetero-
geneous condition, which is currently divided
into different subtypes according to symptoms
at onset.' 2 Among numerous immunological
abnormalities seen in JCA only antinuclear
antibodies and IgM rheumatoid factor are
currently thought to be useful in patient classi-
fication and management.2 3 Some autoanti-
bodies with defined specificity, such as anti-
histone4 5 and anticollagen antibodies,6 7 have
also been detected in patients with JCA, but
their signifcance is still poorly understood.
Anticardiolipin antibodies are antiphospho-
lipid antibodies, which can be found in patients
with systemic lupus erythematosus and other
autoimmune syndromes.8 Their presence has
been correlated with various clinical manifesta-
tions, including thromboembolic phenomena,
autoimmune cytopenia, and neurological
disease.8-'0
In this study we tested 70 patients with JCA
for the presence of anticardiolipin antibodies.
Patients and methods
PATIENTS
Seventy children (26 boys, 44 girls), ranging in
age from 1 year and 5 months to 17 years and 11
months (mean age 8-3 years), whose parents
gave permission for drawing extra blood at the
time of routine venepuncture, were studiedL All
fulfilled the criteria for diagnosis of JCA' and
had been categorised by onset type according to
the criteria of the juvenile rheumatoid arthritis
criteria subcommittee of the American Rheuma-
tism Association (ARA).' The mean disease
duration was 3 5 years. Thirty patients presented
a systemic form, eight a polyarticular, and 32 a
pauciarticular form. To reduce the heterogeneity
of our group patients who were positive for
HLA-B27 or rheumatoid factor were excluded
from the study. Patients were divided according
to disease activity into those with active disease
and those in remission, as previously de-
scribed." At the time of the study 53 patients
had active disease and 17 were in remission.
Thirteen patients were receiving no treatment,
42 were taking non-steroidal anti-inflammatory
drugs (NSAIDs), four were receiving oral slow
acting antirheumatic drugs and NSAIDs, and
11 were receiving low dose steroids in combi-
nation with NSAIDs on alternate days.
Forty two normal healthy children within the
same age range, whose parents gave permission
for drawing extra blood at the time of routine
examinations, served as controls.
In addition, 25 adult patients (20 female, five
male) with rheumatoid arthritis classified
according to the ARA revised criteria,'2 ranging
in age from 28 to 74 years (mean age 45-3 years),
and 40 adult healthy volunteers matched for age
and sex were evaluated for the presence of anti-
cardiolipin antibodies.
METHODS
Serum anticardiolipin antibodies were detected
by an immunosorbent assay by the method of
Gharavi et al'3 with slight modifications. 14
Briefly, serum samples were diluted 1/50 in 10%
fetal calf serum in phosphate buffered saline,
pH 7-4 (PBS-FCS), and incubated in triplicate
for three hours in polyvinyl microtitre plates
previously coated with 25 ml of 50 mg/ml
cardiolipin in ethanol (Sigma Chemical, St
Louis, Missouri, United States), washed in
PBS, and blocked with PBS-FCS for one hour.
After three additional washings the plates were
incubated with a peroxidase conjugated rabbit
antiserum selectively directed to human IgG,
IgM, or IgA (Dakopatts, Denmark) at 1/1000
dilution in PBS-FCS. After three washings 100
ml of 2 mg/ml o-phenylenediamine (Sigma) in
0-1 M phosphate buffer pH 6 plus 300/o H202
was added to each well. The reaction was
stopped by adding 2 M H2SO4, and the optical
density was read at 492 nm with a Titertek
multiscan reader (Flow Laboratories). Upper
normal limits for IgG, IgM, or IgA antibodies
were set as the mean normal values plus five
standard deviations of normal control samples.
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Prevalence of anticardiolipin antibodies in patients with juvenile chronic arthritis and
rheumatoid arthritis and in healthy subjects
Subjects No (%) subjects positive for anticardiolipin antibodies
tested
(n) IgG IgM IgG(only) (only) and IgM
Juvenile chronic arthritis 70 17 (24) 7 (10) 13 (19)
Rheumatoid arthtiris 25 4 (16) 3 (12) 0
Controls-children 42 0 2 (5) 0
Controls-adults 40 0 4 (10) 0
IgG and IgM antibody titre was expressed as
arbitrary units using reference standard serum
samples'5: serum samples with IgG values
ranging from 8 to 15 arb units or IgM from 5 to
15 arb units were defined as low positive, while
values above 15 arb units were considered as
high positive. No standard reference serum
samples were available for titration of IgA
anticardiolipin antibodies.
Statistical analysis was by Wilcoxon's test for
comparison of differences between means and
by linear regression analysis for calculation of
correlation coefficients.
Results
The table and figure show the results of IgG and
IgM anticardiolipin antibody determinations in
patients with JCA, in adults with rheumatoid
arthritis,
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were positive for IgG or IgM antiardiolipin
antibodies, or both, and 30 (43%) for IgG
anticardiolipin antibodies. In contrast, only
seven out of 25 (28%) adult patients with
rheumatoid arthritis presented anticardiolipin
antibodies, which were of IgG class in four cases
(16%). IgG anticardiolipin antibodies were
negative in all control subjects while IgM
anticardiolipin antibodies were present in two
children (5%) and in four adult controls (10%).
Of the 30 patients with JCA positive for IgG
anticardiolipin antibodies, eight (27%) were in
the high positive group and 22 (73%) in the low
positive group. All adult patients with rheuma-
toid arthritis were in the low positive group.
No significant correlations were found in
patients with JCA between anticardiolipin anti-
body titres and clinical subtypes, disease activity
defined on clinical grounds, onset age, disease
duration, presence of iridocyclitis or other
extra-articular manifestations, erythrocyte sedi-
mentation rate, antinuclear antibody positivity,
partial thromboplastin time, outcome, and
treatment. All patients with a high titre of IgG
anticardiolipin antibodies had a raised erythro-
cyte sedimentation rate. No patient presented
with acute occlusive vascular episodes or
cytopenia.
and in healthy controls. Discussion
70 patients with JCA tested, 37 (53%) Our results show a high prevalence (53%) of
anticardiolipin antibodies in patients with JCA.
IgG anticardiolipin antibodies were present in
3l 43% of patients with JCA and a quarter of these
positive cases presented high antibody titres.
The prevalence and the titre of IgG anticardio-
lipin antibodies in patients with JCA were also
markedly higher than those found in a group of
adult patients with rheujmatoid arthritis. This
* finding may be regarded as a further distinctive
feature between JCA and adult onset rheuma-
toid arthritis.
Previous studies on anticardiolipin antibodies
_-_
- u**is. - r -_-_ _ in childhood have focused primarily on systemiclupus erythematosus and related autoimmune
conditions.""'8 In a study of patients with JCA
cCTAL JCA RA aCTRL Leak found a low titre of anticardiolipin anti-bodies in 290/o of patients with antinuclear
antibodies in association with active arthritis
and a poor outcome.'9 Moreover, recently,
Shergy et al reported IgG anticardiolipin anti-
bodies in five of 12 patients with JCA; four of
these patients had also a positive antinuclear
antibody test.
Our study was carried out on a larger series of
patients with JCA and did not show any
association between anticardiolipin antibodies
and antinuclear antibodies or between anti-
cardiolipin antibodies and any other clinical or
laboratory feature. Indeed, the prevalence of
anticardiolipin antibodies in our antinuclear
CCTRLJCA NA antibody positive patients was 50%/o and was
cCTRL JCA PA aCTRL simila to that found in patients with a negative
1(b) IgM anticardiolipin antibody lvels in antinuclear antibody test. A lack of correlationthjuvenile chronic arthritis (7CA), rheumatoid between a positive antinuclear antibody test and
A) and in normal children (cCTRL) and adults anticardiolipin antibodies has been found also in
The values above the dashed line are considered other autoimmune disorders.20 21
tive, those between the dashed and the continuous
positive, and those below the continuous line as It should be noted that all patients with high
.U. =arbitrary units. titre IgG anticardiolipin antibodies had a raised
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erythrocyte sedimentation rate. This finding
might suggest that these antibodies are present
in high titre only in patients with active disease;
no correlation was found between anticardio-
lipin antibodies and erythrocyte sedimentation
rate or disease activity defined on clinical
grounds, however.
The presence of anticardiolipin antibodies is
often associated with circulating anticoagulant
activity and with distinctive clinical features,
including deep vein and arterial thromboses,
autoimmune cytopenia, cutaneous necroses,
and neurological disease; this clinical picture is
currently defined as 'anticardiolipin syn-
drome'.'0 This syndrome has been reported
more often in patients with IgG anticardiolipin
antibodies and high antibody titres'3 22 and has
been found also in children.'7 "8'We found no
association between anticardiolipin antibodies
and either abnormal clotting tests or specific
clinical features in our patients with JCA,
however, despite a large number of cases with
high titre IgG anticardiolipin antibodies. This is
in accordance with the general view that the
clinical and biological significance of these
antibodies may be different in different con-
ditions.9 23
In conclusion, our study showed a high
prevalence of anticardiolipin antibodies in JCA.
The prevalence and the titre of anticardiolipin
antibodies in patients with JCA were much
higher than those found in adult rheumatoid
arthritis. No correlations were found between
anticardiolipin antibodies and specific clinical
and laboratory features. Further studies are
needed to clarify the significance of these
antibodies in JCA and their possible usefulness
in further defining the heterogeneity of this
condition.
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